Bg pattern

EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Ebastine Teva-ratiopharm 10 mg Oral Dispersible Tablets EFG

Ebastine Teva-ratiopharm 20 mg Oral Dispersible Tablets EFG

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

Keep this package leaflet, as you may need to read it again.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms of illness as you, as it may harm them.

If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet:

  1. What is Ebastine Teva-ratiopharm and what is it used for?
  2. What you need to know before taking Ebastine Teva-ratiopharm?
  3. How to take Ebastine Teva-ratiopharm?
  4. Possible side effects?
  5. Storage of Ebastine Teva-ratiopharm?
  6. Contents of the pack and further information.

1. What is Ebastine Teva-ratiopharm and what is it used for?

Ebastine is an antihistamine that helps relieve allergy symptoms such as sneezing, runny nose, itchy eyes, and itchy skin rashes.

In adults and children 12 years and older, Ebastine Teva-ratiopharm is used to relieve symptoms of seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis, including cases with allergic conjunctivitis.

In adults over 18 years, Ebastine Teva-ratiopharm 10 mg is also used to relieve itching and the development of hives, urticaria (hives).

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Ebastine Teva-ratiopharm

Do not take Ebastine Teva-ratiopharm:

  • If you are allergic (hypersensitive) to ebastine or any of the other ingredients of Ebastine Teva-ratiopharm (listed in section 6).

Warnings and precautions

Consult your doctor before starting to take Ebastine Teva-ratiopharm if:

  • you have low potassium levels in your blood.
  • you have an abnormal heart rhythm (known as QTc interval prolongation in the ECG), which can occur in some types of heart disease.

If you are already taking certain antibiotics or medications used to treat fungal infections: see the section "Ebastine Teva-ratiopharm with other medications" below.

  • If you have severe liver function impairment (liver failure).
    • Ebastine may cause dry mouth. Therefore, during prolonged treatment with ebastine, it is essential to maintain good oral hygiene (brush your teeth twice a day) to reduce the risk of caries.

Children and adolescents

This medication should only be used by children 12 years and older. Do not give this medication to children under 12 years, as safety and efficacy have not been established in this age group.

Taking Ebastine Teva-ratiopharm with other medications

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medication.

Ebastine Teva-ratiopharm may affect or be affected by other medications that contain the following active ingredients:

  • ketoconazole, itraconazole (active ingredients for the treatment of fungal infections).
  • erythromycin (antibiotic).
  • rifampicin (medication used to treat tuberculosis).

Taking Ebastine Teva-ratiopharm with food and drinks

The tablets can be taken with or without food.

Pregnancy, breastfeeding, and fertility

Experience with the use of ebastine in pregnant women is limited, so it is recommended to consult a doctor before taking Ebastine Teva-ratiopharm.

It is unknown whether ebastine is excreted in breast milk. Ebastine Teva-ratiopharm is contraindicated during breastfeeding.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Driving and using machines

Most patients treated with Ebastine Teva-ratiopharm can drive or perform other activities that require good reaction ability. However, as with all other medications, you should check your individual reaction after taking Ebastine Teva-ratiopharm before driving or performing complex activities, as some patients experience drowsiness or dizziness.

Ebastine Teva-ratiopharm contains aspartame

Ebastine Teva-ratiopharm 10 mg contains 2.5 mg of aspartame in each tablet. Ebastine Teva-ratiopharm 20 mg contains 5 mg of aspartame in each tablet.

Aspartame contains a source of phenylalanine, which may be harmful in case of phenylketonuria (PKU), a rare genetic disease in which phenylalanine accumulates because the body cannot eliminate it properly.

Ebastine Teva-ratiopharm contains lactose

If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

Ebastine Teva-ratiopharm contains sodium

This medication contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially "sodium-free".

3. How to take Ebastine Teva-ratiopharm

Follow the administration instructions of ebastine indicated by your doctor or pharmacist exactly. In case of doubt, consult your doctor or pharmacist again.

The recommended dose is:

Indication

Age

Dose

Allergic rhinitis

In case of severe symptoms

Children 12 years and older and adults

One tablet of ebastine 10 mg (10 mg of ebastine) per day

Two tablets of ebastine 10 mg or one tablet of ebastine 20 mg (20 mg of ebastine) per day

Urticaria

Adults over 18 years

One tablet of ebastine 10 mg (10 mg of ebastine) per day

In patients with renal insufficiency, no dose adjustment is necessary.

In patients with mild to moderate liver insufficiency, no dose adjustment is necessary.

There is no experience with doses greater than 10 mg in patients with severe liver insufficiency; therefore, the dose should not exceed 10 mg in these patients.

Do not push the tablet out of the blister, as this will crush it.

Each strip contains separate tablets separated by perforations in blisters. Separate one blister with its tablet along the dotted line (Figure 1)

Hand applying a medicinal patch to the skin with a black arrow indicating the direction of application and the number one

Carefully remove the peel-off foil from the edge indicated by the arrow (Figures 2 and 3)

Two fingers holding a device with a circular button and a black arrow pointing upwardsHands holding a white rectangular device with a black arrow pointing upwards number three below

Keep your hands dry and take the tablet from the strip.

Place the tablet on the tongue where it will disperse: no water or other liquid is needed.

You can take ebastine independently of meals.

Your doctor will decide the duration of treatment.

If you take more Ebastine Teva-ratiopharm than you should

There is no specific antidote for the active ingredient ebastine.

If you suspect an overdose with ebastine, inform your doctor. Depending on the severity of the poisoning, he/she will initiate the necessary measures (control of the body's vital functions, including ECG monitoring for at least 48 hours, symptomatic treatment, and gastric lavage), if necessary.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service. Phone 915 620 420 indicating the name of the medication and the amount ingested.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

If you forget to take Ebastine Teva-ratiopharm

Do not take a double dose to make up for forgotten doses.

If you have any other questions about the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medications, this medication can have side effects, although not everyone gets them.

Stop taking Ebastine Teva-ratiopharm and contact your doctor immediately or go to the nearest hospital if the following occurs:

  • Itching, hives, and swelling of the face, tongue, or throat that can cause difficulty swallowing or breathing. These can be signs of a hypersensitivity reaction such as anaphylaxis and angioedema, which are rare side effects (may affect up to 1 in 1,000 people).

Other side effects

Very common side effectsmay affect more than 1 in 10 people

  • Headache.

Common side effectsmay affect up to 1 in 10 people

  • Drowsiness.
  • Dry mouth.

Uncommon side effectsmay affect up to 1 in 100 people

  • Nosebleeds.
  • Sore throat (pharyngitis).
  • Nasal discharge (rhinitis).

Rare side effectsmay affect up to 1 in 1,000 people

  • Nervousness.
  • Insomnia.
  • Drowsiness.
  • Dizziness.
  • Abnormal or decreased sense of touch.
  • Abnormal sense of taste.
  • Palpitations (rapid or irregular heartbeat).
  • Fast heartbeat.
  • Abdominal pain.
  • Vomiting.
  • Nausea.
  • Indigestion.
  • Hepatitis (liver inflammation).
  • Cholestasis (altered bile flow).
  • Abnormal liver function tests.
  • Rash, hives, widespread diffuse urticaria.
  • Menstrual cramps.
  • Edema (fluid accumulation in tissues).
  • Weakness (asthenia).

Very rare side effectsmay affect up to 1 in 10,000 people

  • Dysesthesia (abnormal sensitivity).
  • Eczema, skin inflammation.
  • Menstrual cramps.

Frequency not knowncannot be estimated from the available data

  • Weight gain.
  • Increased appetite.

Reporting side effects

If you experience any side effects, consult your doctor, even if they are side effects not listed in this package leaflet. You can also report them through the Spanish Medicines Monitoring System Website: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Ebastine Teva-ratiopharm

  • Keep this medication out of the sight and reach of children.
  • Do not use this medication after the expiration date stated on the packaging after EXP. The expiration date is the last day of the month indicated.
  • Store in the original packaging to protect it from light.
  • Medications should not be disposed of via wastewater or household waste. Place the packaging and any unused medication in the SIGRE collection point at your usual pharmacy. Ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Contents of the pack and further information

Composition of Ebastine Teva-ratiopharm

  • The active ingredient is ebastine. Each oral dispersible tablet contains 10 mg of ebastine. Each oral dispersible tablet contains 20 mg of ebastine.
  • The other ingredients (excipients) are microcrystalline cellulose, lactose monohydrate, cornstarch, sodium croscarmellose, aspartame (E951), peppermint flavor, colloidal anhydrous silica, and magnesium stearate.

Appearance of the product and contents of the pack

  • Oral dispersible tablets.
  • Ebastine Teva-ratiopharm 10 mg: white, biconvex, round tablets, engraved with "E10" on one side and flat on the other.

Ebastine Teva-ratiopharm 20 mg: white, biconvex, round tablets, engraved with "E20" on one side and flat on the other.

  • Available pack sizes:

10 mg: 10, 20, 30, 40, 50, 90, 98, and 100 oral dispersible tablets.

20 mg: 10, 15, 20, 30, 40, 50, 98, and 100 oral dispersible tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder:

Teva Pharma, S.L.U.

C/ Anabel Segura, 11, Edificio Albatros B, 1ª planta, Alcobendas.

28108 Madrid.

Manufacturer:

Teva Pharma, S.L.U.

C/ C, n 4 Polígono Industrial Malpica.

Zaragoza 50016.

Spain.

or

Teva Pharmaceutical Works Private Limited Company.

Pallagi út 13, 4042 Debrecen.

Hungary.

or

Teva Czech Industries S.R.O.

Ostravska 29, c.p. 305, - Opava-Komarov - 747 70.

Czech Republic.

or

Pharmachemie B.V.

Swensweg 5, 2031 GA Haarlem.

Netherlands.

Date of the last revision of this package leaflet:September 2024.

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.

You can access detailed and updated information about this medication by scanning the QR code included in the packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/74991/P_74991.html.

Online doctors for EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS

Discuss questions about EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS?
EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS?
The active ingredient in EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS is ebastine. This information helps identify medicines with the same composition but different brand names.
How much does EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS cost in pharmacies?
The average pharmacy price for EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS is around 8.79 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS?
EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS is manufactured by Teva Pharma S.L.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to EBASTINE TEVA-RATIOPHARM 20 mg ORALLY DISINTEGRATING TABLETS?
Other medicines with the same active substance (ebastine) include BACTIL 10 mg FILM-COATED TABLETS, BACTIL FLAS 10 mg ORAL LYOPHILIZED, BACTIL FORTE 20 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media